These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The idiopathic QT syndrome as the cause of epileptic and nonepileptic seizures]. Hördt M, Haverkamp W, Oberwittler C, Lüdemann P, Borggrefe M, Ringelstein EB, Breithardt G. Nervenarzt; 1995 Apr; 66(4):282-7. PubMed ID: 7783815 [Abstract] [Full Text] [Related]
25. Hands-on help Torsades de pointes. Dulak SB. RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376 [Abstract] [Full Text] [Related]
26. Early afterdepolarizations, U waves, and torsades de pointes. Wu J, Wu J, Zipes DP. Circulation; 2002 Feb 12; 105(6):675-6. PubMed ID: 11839619 [No Abstract] [Full Text] [Related]
27. A practical approach to torsade de pointes. Roden DM. Clin Cardiol; 1997 Mar 12; 20(3):285-90. PubMed ID: 9068917 [Abstract] [Full Text] [Related]
28. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Khan IA, Gowda RM. Int J Cardiol; 2004 May 12; 95(1):1-6. PubMed ID: 15159030 [Abstract] [Full Text] [Related]
29. [Short coupled variant of "torsades de pointes" and sudden death]. Hentati M, Krichene S, Kechida Z, Chahbani I, Hached L, Grati Z, Charfeddine H, Kammoun S. Tunis Med; 2004 Jun 12; 82(6):542-5. PubMed ID: 15517954 [Abstract] [Full Text] [Related]
31. Ventricular tachyarrhytmias in the absence of structural heart disease. Coumel P, Jazra C. J Med Liban; 1999 Jun 12; 47(3):178-80. PubMed ID: 10550943 [No Abstract] [Full Text] [Related]
32. [Torsades de pointes: analysis of 105 episodes]. Maia IG, Sá R, Alves PA, Ribeiro JC, Fernandes PH, Guarçoni O, Bassan R, Dohmann HF. Rev Port Cardiol; 1993 Feb 12; 12(2):163-8. PubMed ID: 8461156 [Abstract] [Full Text] [Related]
33. Drug-induced QT prolongation and proarrhythmia: an inevitable link? Ahmad K, Dorian P. Europace; 2007 Sep 12; 9 Suppl 4():iv16-22. PubMed ID: 17766320 [Abstract] [Full Text] [Related]
34. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone]. Makai A, Rudas L, Liszkai G, Fazekas T. Orv Hetil; 2003 Feb 02; 144(5):241-7. PubMed ID: 12647553 [Abstract] [Full Text] [Related]
35. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs]. Fazekas T, Liszkai G. Orv Hetil; 2005 Mar 06; 146(10):451-60. PubMed ID: 15835343 [Abstract] [Full Text] [Related]
36. The perfect storm: Torsades de Pointes in a child with leukemia. Bagatell R, Hainstock M, Lowe MC, Barber BJ, Samson RA. Pediatr Blood Cancer; 2007 Dec 06; 49(7):996-9. PubMed ID: 16333840 [Abstract] [Full Text] [Related]
38. Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes. Bar-Meir E, Schein O, Eisenkraft A, Rubinshtein R, Grubstein A, Militianu A, Glikson M, CBRN Medical Branch, Medical Corps, Israel Defense Forces. Crit Rev Toxicol; 2007 Mar 06; 37(3):279-85. PubMed ID: 17453935 [Abstract] [Full Text] [Related]
39. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval]. Calderone V, Cavero I. Minerva Med; 2002 Jun 06; 93(3):181-97. PubMed ID: 12094149 [Abstract] [Full Text] [Related]
40. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. Kirchhof P, Franz MR, Bardai A, Wilde AM. J Am Coll Cardiol; 2009 Jul 07; 54(2):143-9. PubMed ID: 19573731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]